Reneo Pharmaceuticals, Inc.
SEC Filing List
RPHM CIK: 0001637715
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | Toppan Merrill/FA | 05/15/2026 | |||
| 8-K | Current report filing | Onkure Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/05/2026 | |
| 10-Q | Quarterly report pursuant to Section 13 ... | Onkure Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/05/2026 | |
| EFFECT | Effectiveness refer to a Registration St... | cik 9999999995 /fa | 05/04/2026 | ||
| S-3 | Registration statement for specified tra... | Onkure Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/24/2026 | |
| DEF 14A | Definitive proxy statements | Onkure Therapeutics, Inc. | Broadridge Financial Solutions, Inc. /fa | 04/21/2026 | |
| ARS | Annual report to security holders | Onkure Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/21/2026 | |
| DEFA14A | Definitive additional proxy soliciting m... | Onkure Therapeutics, Inc. | Broadridge Financial Solutions, Inc. /fa | 04/21/2026 | |
| SCHEDULE 13G | 04/07/2026 | ||||
| SCHEDULE 13G | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/07/2026 | |||
| No record found. | |||||
| Load More | |||||
